iOnctura SA

iOnctura, a UK-based biotech company, is making significant strides in the field of oncology under the leadership of CEO Catherine Pickering. The company is focused on developing innovative therapies

The past year has seen an increase in investment in biopharma companies following a couple of lean years, but the sector is not fully out of the woods yet. However, most industry leaders see funding

Venture capital mega-rounds of $100m or more have surged in 2024 and the trend has continued in December, with announcements on 19 December that Ottimo Pharma’s series A round brought in more than $14

Decent-sized fundraisings have been few and far between in Europe of late but the Swiss/Dutch cancer specialist iOnctura SA has bucked the trend with a €80m series B financing. The round was led by